Company: HURA
Filing Date: 2025-05-23
Form Type: 424B3
Source: 0001193125-25-125499
Chunk: 513

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-23
Form: 424B3
Chunk 513
---
,067.50 |     |            | 9/5/2029   |
|                                                                                  |     |             |        68 |    |     |               |       — |    |     | $         |  2,975.00 |     |            | 9/15/2030  |
|                                                                                  |     |             |        57 |    |     |               |       — |    |     | $         |  2,170.00 |     |            | 9/22/2031  |
|                                                                                  |     |             |     2,010 |    |     |               |       — |    |     | $         |  1,680.00 |     |            | 11/8/2031  |
|                                                                                  |     |             |       686 |    |     |               |       — |    |     | $         |    307.48 |     |            | 8/1/2032   |
|                                                                                  |     |             |       661 |    |     |               |       — |    |     | $         |    162.93 |     |            | 8/30/2033  |

| (1) | This option vests, in arrears, in three equal annual installments over three years from the grant date of 
 April 7, 2023, subject to his continuous service on each vesting date.                                    |

| (2) | This option vests, in arrears, in three equal annual installments over three years from the grant date of 
 November 15, 2022, subject to his continuous service on each vesting date.                                |

| (3) | This option vests, in arrears, in three equal annual installments over three years from the grant date of 
 February 28, 2023, subject to his continuous service on each vesting date.                                |

| (4) | This option vests, in arrears, in three equal annual installments over three years from the grant date of 
 November 12, 2024, subject to his continuous service on each vesting date.                                |

| (5) | Pursuant to the Hoffman Amendment, all of Mr. Hoffman’s outstanding options vested in full on 
 October 4, 2024.                                                                              |

328

Additional Narrative Disclosure

Potential Payments Upon Termination or Change in Control

Under the employment agreements with